InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

LENZ Therapeutics, Inc.

LENZ Clue Score42
United States Fiscal year ends December CIK 0001815776 Results filed 28 Oct 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

8
Insider
Date
Role
Action
Shares
Price
Amount
Shawn Olsson
9 Apr 2025
Chief Commercial Officer
Exercised, kept
1,400
$2.08
$2.91K
Evert B. Schimmelpennink
7 Mar 2025
President, CEO and Secretary
Exercised, kept
4,200
$1.04
$4.37K
Shawn Olsson
16 Dec 2024
Chief Commercial Officer
Exercised, kept
3,333
$2.08
$6.93K
Evert B. Schimmelpennink
22 Jul 2024
President, CEO and Secretary
Exercised, kept
45,000
$1.04
$46.80K
Phil Gutry
18 Apr 2021
Chief Business Officer
Exercised, kept
3,383
$6.11
$20.67K
Joshua Lehrer-Graiwer
16 Jan 2021
President and CEO
Exercised, kept
374,013
$0.30
$112.20K
Phil Gutry
15 Jan 2021
Chief Business Officer
Exercised, kept
91,406
$0.30
$27.42K
Joseph Jimenez
14 Jan 2021
Director
Exercised, kept
49,876
$0.30
$14.96K
Show all 77 transactions →

What was left out

Form 4 filings counted 100
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 22
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 2
Sales at will 37
Transactions with no price 2
Shares from compensation/vesting 39,830,610
History held since 28 Jun 2021